Onpattro 10 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DR26FMDU0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,377
Award facts
- Contract value 100% obligated
- $28,376.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $28,376.64 by the Defense Logistics Agency on October 28, 2025, for the supply of Onpattro (patisiran) 10 mg/5 ml vials. The award utilizes a firm fixed-price structure with no set-aside designation, indicating the company competed in an unrestricted procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.9 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V program represents part of the Defense Logistics Agency's broader $30.3 billion acquisition strategy to establish multiple regional prime vendor contractors for pharmaceutical supply to military healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial contracting activity with DLA's Medical Supply Chain division, supplying an extensive portfolio including specialty pharmaceuticals, biologics, oncology treatments, immunosuppressants, vaccines, and medical consumables. The delivery order is funded by the Defense Logistics Agency and is scheduled for completion by November 19, 2025, with performance to occur at the contractor's Park Ridge, Illinois facility.
Quick answers
Who was awarded contract SPE2DR26FMDU0?
SPE2DR26FMDU0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FMDU0 worth?
The government has obligated $28,377 on SPE2DR26FMDU0.
Is contract SPE2DR26FMDU0 an order under another contract?
Yes. SPE2DR26FMDU0 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDU0 competed?
The extent of competition for SPE2DR26FMDU0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award